Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Xue-mei Peng"'
Autor:
Xin-li Cao, Xue-mei Peng, Gong-bo Li, Wei-sen Ding, Kai-zhen Wang, Xiao-lei Wang, Yan-ying Xiong, Wei-jian Xiong, Fan Li, Min Song
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionChaihu-Longgu-Muli decoction (CLMD) is a well-used ancient formula originally recorded in the “Treatise on Febrile Diseases” written by the founding theorist of Traditional Chinese Medicine, Doctor Zhang Zhongjing. While it has been u
Externí odkaz:
https://doaj.org/article/94389db0a57c469088b57a77ad5c57e2
Autor:
Jie Li, Tai-Ran Bai, Shan Gao, Zhuan Zhou, Xue-Mei Peng, Li-Song Zhang, Dao-Lei Dou, Zhi-Song Zhang, Lu-Yuan Li
Publikováno v:
EBioMedicine, Vol 36, Iss , Pp 229-240 (2018)
Background: Epidermal growth factor receptor (EGFR) signalling is critical in epithelial cancer development. Human rhomboid family-1 (RHBDF1) facilitates the secretion of TGFα, an EGFR ligand, in breast cancer; however, the underlying mechanism rema
Externí odkaz:
https://doaj.org/article/4de3c6947a394bef904e5650ff431a1d
Autor:
Pei Shuang Li, Xue Mei Peng, Xiang Xin Niu, Ling Xu, Ernest Hung Yu Ng, Chi Chiu Wang, Jin Fang Dai, Jun Lu, Rui Ning Liang
Publikováno v:
Fertility and Sterility. 119:815-823
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe11d47a9a8389895c815315668113b5
https://doi.org/10.1016/j.fertnstert.2023.01.034
https://doi.org/10.1016/j.fertnstert.2023.01.034
Publikováno v:
Disease Markers
Disease Markers, Vol 2021 (2021)
Disease Markers, Vol 2021 (2021)
Objective. Growing evidence shows that enhancer RNAs (eRNAs) are pivotal for tumor progression. In this research, our team aimed to identify the survival-related eRNAs and further explore their potential function in glioblastoma (GBM). Methods. RNA-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e08fd53fe7d29af0d0b7fd84883809
https://pubmed.ncbi.nlm.nih.gov/35003394
https://pubmed.ncbi.nlm.nih.gov/35003394
Publikováno v:
Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology. 37(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b1c28b02a45482420b94aa2d2ce91c56
https://pubmed.ncbi.nlm.nih.gov/34374262
https://pubmed.ncbi.nlm.nih.gov/34374262
Autor:
Xue-Mei Peng, Zhuan Zhou, Jie Li, Shan Gao, Lu-Yuan Li, Zhi-Song Zhang, Tai-Ran Bai, Dao-Lei Dou, Li-Song Zhang
Publikováno v:
EBioMedicine
Background Epidermal growth factor receptor (EGFR) signalling is critical in epithelial cancer development. Human rhomboid family-1 (RHBDF1) facilitates the secretion of TGFα, an EGFR ligand, in breast cancer; however, the underlying mechanism remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d180894191a3332d2f40fe06322168e5
https://doi.org/10.1016/j.ebiom.2018.09.038
https://doi.org/10.1016/j.ebiom.2018.09.038
Autor:
Lu-Yuan Li, Hui-Ting Deng, Guo-Ce Xu, Qiang-Zhe Zhang, Xue-Mei Peng, Hai-Lin Liu, Kun Zhang, Bei-Bei Zhai
Publikováno v:
FEBS Open Bio
Tumor necrosis factor superfamily-15 (TNFSF15; VEGI; TL1A) is a negative modulator of angiogenesis for blood vessel homeostasis and is produced by endothelial cells in a mature vasculature. It is known to be downregulated by vascular endothelial grow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1effc9812b74898807bb824398bd7b1
http://europepmc.org/articles/PMC5221472
http://europepmc.org/articles/PMC5221472
Autor:
Hong-Xing Cai, Rong Xiang, Shan Gao, Qiang-Zhe Zhang, Zhuan Zhou, Hui-Ting Deng, Xue-Mei Peng, Lu-Yuan Li
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 32(10)
The human rhomboid family (RHBDF)1 gene is highly expressed in breast cancer under clinical conditions but not in normal mammary gland tissues. Silencing the RHBDF1 gene in breast cancer xenograft tumors leads to inhibition of tumor growth. We show i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8a2f53953078d07cb0a11d1c41db997
https://pubmed.ncbi.nlm.nih.gov/29727209
https://pubmed.ncbi.nlm.nih.gov/29727209
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 36(10)
To compare the pharmacokinetics of cisatracurium between normal weight patients and morbidly obese patients.Twelve obese ASA I-II patients (BMI≥35 kg/mCompared with those measured at TCisatracurium doses according to fat-free mass is clinically rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c4ac24a726cc5a6befbcb8f41cff99a2
https://pubmed.ncbi.nlm.nih.gov/27777205
https://pubmed.ncbi.nlm.nih.gov/27777205
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 36(2)
To investigate the effects of perfluorocarbon and ligustrazine in protecting the lungs against ischemia-reperfusion injury in rats.Forty SD rats with ischemia-reperfusion lung injury were randomized equally into control, ligustrazine, perfluorocarbon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b54e574984d8e298c2be1645bc296a9c
https://pubmed.ncbi.nlm.nih.gov/26922025
https://pubmed.ncbi.nlm.nih.gov/26922025